Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.42
-0.18 (-1.43%)
At close: Jul 31, 2025, 4:00 PM
12.15
-0.27 (-2.17%)
After-hours: Jul 31, 2025, 6:53 PM EDT

Crescent Biopharma Analyst Ratings

Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$25.67
Upside
+106.68%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wedbush
Wedbush
Buy
Initiates
$27
BuyInitiates$27+117.39%Jul 14, 2025
Stifel
Stifel
Strong Buy
Initiates
$28
Strong BuyInitiates$28+125.44%Jun 25, 2025
LifeSci Capital
LifeSci Capital
Buy
Initiates
$22
BuyInitiates$22+77.13%Jun 18, 2025
Raymond James
Raymond James
Hold
Downgrades
n/a
HoldDowngradesn/an/aNov 15, 2021
Raymond James
Raymond James
Buy
Maintains
$285$270
BuyMaintains$285$270+2,073.91%Aug 6, 2021
Raymond James
Raymond James
Buy
Maintains
$270$285
BuyMaintains$270$285+2,194.69%Apr 29, 2021
Piper Sandler
Piper Sandler
Buy
Initiates
$225
BuyInitiates$225+1,711.59%Feb 10, 2021
Raymond James
Raymond James
Buy
Maintains
$300$270
BuyMaintains$300$270+2,073.91%Feb 4, 2021
B. Riley Securities
B. Riley Securities
Hold
Downgrades
$660$188
HoldDowngrades$660$188+1,409.66%Jun 21, 2018
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$285$735
Strong BuyMaintains$285$735+5,817.87%Feb 12, 2018
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$150$1,125
Strong BuyMaintains$150$1,125+8,957.97%Feb 9, 2018
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$285
Strong BuyInitiates$285+2,194.69%Dec 8, 2017
Chardan Capital
Chardan Capital
Strong Buy
Initiates
$150
Strong BuyInitiates$150+1,107.73%Jun 12, 2017
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$165
Strong BuyInitiates$165+1,228.50%Jun 6, 2017